BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16543919)

  • 1. The rationale for prophylactic cancer vaccines and need for a paradigm shift.
    Sobol RE
    Cancer Gene Ther; 2006 Aug; 13(8):725-31. PubMed ID: 16543919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
    Spisek R
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer vaccines: between the idea and the reality.
    Finn OJ
    Nat Rev Immunol; 2003 Aug; 3(8):630-41. PubMed ID: 12974478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination for treatment and prevention of cancer in animal models.
    Cavallo F; Offringa R; van der Burg SH; Forni G; Melief CJ
    Adv Immunol; 2006; 90():175-213. PubMed ID: 16730264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical development of MVA-based therapeutic cancer vaccines.
    Acres B; Bonnefoy JY
    Expert Rev Vaccines; 2008 Sep; 7(7):889-93. PubMed ID: 18767940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer vaccines inducing antibody production: more pros than cons.
    Jensen-Jarolim E; Singer J
    Expert Rev Vaccines; 2011 Sep; 10(9):1281-9. PubMed ID: 21919618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
    Lévy F; Colombetti S
    Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cancer-fighting implant?
    Marron K
    Lab Anim (NY); 2009 Mar; 38(3):72. PubMed ID: 19229213
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer vaccines: promise for the future or pipe dream?
    Mittendorf EA; Peoples GE; Singletary SE
    Cancer; 2007 Oct; 110(8):1677-86. PubMed ID: 17763371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
    Nedospasov SA; Kuprash DV
    Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching of optimal vaccination schedules: application of genetic algorithms to approach the problem in cancer immunoprevention.
    Pennisi MA; Pappalardo F; Zhang P; Motta S
    IEEE Eng Med Biol Mag; 2009; 28(4):67-72. PubMed ID: 19622427
    [No Abstract]   [Full Text] [Related]  

  • 13. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
    Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
    J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines to treat cancer--an old approach whose time has arrived.
    Hellstrom KE; Hellstrom I
    J Cell Biochem; 2007 Oct; 102(2):291-300. PubMed ID: 17729239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of tumor cell-based vaccines.
    Copier J; Dalgleish A
    Int Rev Immunol; 2006; 25(5-6):297-319. PubMed ID: 17169778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer vaccines: a promising cancer therapy against all odds.
    Silk AW; Finn OJ
    Future Oncol; 2007 Jun; 3(3):299-306. PubMed ID: 17547525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue vaccines for cancer.
    Suckow MA; Heinrich J; Rosen ED
    Expert Rev Vaccines; 2007 Dec; 6(6):925-37. PubMed ID: 18377356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pilot trial of vaccines based on autologous dendritic cells loaded in vitro with tumor antigens in the treatment of cancer of the urinary bladder].
    Shoua AB; Sergienco NF; Sitnikov NV; Chkadua GZ
    Urologiia; 2008; (5):54-7. PubMed ID: 19069498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenogenic cancer vaccines.
    Potebnya GP; Symchych TV; Lisovenko GS
    Exp Oncol; 2010 Jul; 32(2):61-5. PubMed ID: 20693963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.